title: Important role of indels in somatic mutations of human cancer genes.
abstract: BACKGROUND
  Cancer is clonal proliferation that arises owing to mutations in a subset of genes that confer growth advantage. More and more cancer related genes are found to have accumulated somatic mutations. However, little has been reported about mutational patterns of insertions/deletions (indels) in these genes.
  
  
  RESULTS
  We analyzed indels' abundance and distribution, the relative ratio between indels and somatic base substitutions and the association between those two forms of mutations in a large number of somatic mutations in the Catalogue of Somatic Mutations in Cancer database. We found a strong correlation between indels and base substitutions in cancer-related genes and showed that they tend to concentrate at the same locus in the coding sequences within the same samples. More importantly, a much higher proportion of indels were observed in somatic mutations, as compared to meiotic ones. Furthermore, our analysis demonstrated a great diversity of indels at some loci of cancer-related genes. Particularly in the genes with abundant mutations, the proportion of 3n indels in oncogenes is 7.9 times higher than that in tumor suppressor genes.
  
  
  CONCLUSIONS
  There are three distinct patterns of indel distribution in somatic mutations: high proportion, great abundance and non-random distribution. Because of the great influence of indels on gene function (e.g., the effect of frameshift mutation), these patterns indicate that indels are frequently under positive selection and can often be the 'driver mutations' in oncogenesis. Such driver forces can better explain why much less frameshift mutations are in oncogenes while much more in tumor suppressor genes, because of their different function in oncogenesis. These findings contribute to our understanding of mutational patterns and the relationship between indels and cancer.
authors.affiliation: State Key Laboratory of Pharmaceutical Biotechnology, Department of Biology, Nanjing University, Nanjing 210093, China.
authors.forename: Haiwang
authors.initials: H
authors.lastname: Yang
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhong
authors.forename: Cheng
authors.initials: C
authors.lastname: Peng
authors.forename: Jian-Qun
authors.initials: JQ
authors.lastname: Chen
authors.forename: Dacheng
authors.initials: D
authors.lastname: Tian
mesh_terms: D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics; D016208:Databases, Factual; D052138:Genes, Neoplasm; D006801:Humans; D054643:INDEL Mutation; D009369:Neoplasms / Q000235:genetics*; D009857:Oncogenes; D025521:Tumor Suppressor Proteins / Q000235:genetics
chemical_list: D022762:CCAAT-Enhancer-Binding Proteins; C515848:CEBPA protein, human; D025521:Tumor Suppressor Proteins
references.citation: Hum Genet. 2005 May;116(6):433-44
references.pmid: 15726414
references.citation: Gene. 2003 Jul 17;312:257-61
references.pmid: 12909362
references.citation: Nature. 2010 Jan 14;463(7278):191-6
references.pmid: 20016485
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: Nucleic Acids Res. 2010 Jan;38(Database issue):D652-7
references.pmid: 19906727
references.citation: Hum Mutat. 2003 Jan;21(1):12-27
references.pmid: 12497628
references.citation: Br J Cancer. 2004 Jul 19;91(2):355-8
references.pmid: 15188009
references.citation: Nat Rev Genet. 2006 Jan;7(1):21-33
references.pmid: 16369569
references.citation: Science. 1976 Oct 1;194(4260):23-8
references.pmid: 959840
references.citation: Mov Disord. 2004 Oct;19(10):1146-57
references.pmid: 15390068
references.citation: Cancer Res. 2004 Aug 1;64(15):5518-24
references.pmid: 15289363
references.citation: Genetica. 2002 May;115(1):81-91
references.pmid: 12188050
references.citation: Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.11
references.pmid: 18428421
references.citation: Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207
references.pmid: 20177395
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: Nature. 2008 Sep 4;455(7209):105-8
references.pmid: 18641631
references.citation: Hum Mutat. 2000;16(2):109-22
references.pmid: 10923032
references.citation: Nat Rev Cancer. 2004 Mar;4(3):177-83
references.pmid: 14993899
references.citation: Mol Biol Evol. 2009 Oct;26(10):2353-61
references.pmid: 19587128
references.citation: Nature. 2001 May 17;411(6835):336-41
references.pmid: 11357140
references.citation: Trends Genet. 2002 Nov;18(11):544-7
references.pmid: 12414177
references.citation: Bioessays. 2009 Sep;31(9):912-20
references.pmid: 19644920
references.citation: Cancer Res. 2009 Oct 15;69(20):8094-101
references.pmid: 19789351
references.citation: Nat Rev Cancer. 2005 Feb;5(2):113-25
references.pmid: 15660110
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11642-6
references.pmid: 16868089
references.citation: Nature. 2009 Apr 9;458(7239):719-24
references.pmid: 19360079
references.citation: Nature. 2009 Aug 20;460(7258):1011-5
references.pmid: 19587683
references.citation: Science. 1996 May 3;272(5262):725-8
references.pmid: 8614834
references.citation: BMC Genomics. 2007 Jun 20;8:185
references.pmid: 17584915
references.citation: Nature. 2009 Jan 1;457(7225):36-7
references.pmid: 19122629
references.citation: Genome Res. 2003 Jan;13(1):13-26
references.pmid: 12529302
references.citation: Mol Biol Evol. 2009 Jul;26(7):1523-31
references.pmid: 19329651
references.citation: FASEB J. 2008 Aug;22(8):2605-22
references.pmid: 18434431